Related references
Note: Only part of the references are listed.Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
Emilia Falkowska et al.
IMMUNITY (2014)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nicole A. Doria-Rose et al.
NATURE (2014)
Vaccine design: emerging concepts and renewed optimism
Sebastian K. Grimm et al.
CURRENT OPINION IN BIOTECHNOLOGY (2013)
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
Andrew T. McGuire et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Rapid Conformational Epitope Mapping of Anti-gp120 Antibodies with a Designed Mutant Panel Displayed on Yeast
Jordi Mata-Fink et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao et al.
NATURE (2013)
Mapping the Journey to an HIV Vaccine
Margaret Ackerman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation
Rajesh P. Ringe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Jean-Philippe Julien et al.
SCIENCE (2013)
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
Dmitry Lyumkis et al.
SCIENCE (2013)
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Joseph Jardine et al.
SCIENCE (2013)
Increased Functional Stability and Homogeneity of Viral Envelope Spikes through Directed Evolution
Daniel P. Leaman et al.
PLOS PATHOGENS (2013)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders et al.
PLOS PATHOGENS (2013)
Emerging Concepts on the Role of Innate Immunity in the Prevention and Control of HIV Infection
Margaret E. Ackerman et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study
Barton F. Haynes et al.
NATURE BIOTECHNOLOGY (2012)
Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape
Penny L. Moore et al.
NATURE MEDICINE (2012)
HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120
James M. Kovacs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site
Fatima K. Ahmed et al.
VACCINE (2012)
Fine epitope mapping of monoclonal antibodies against hemagglutinin of a highly pathogenic H5N1 influenza virus using yeast surface display
Thomas Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Protein folding and quality control in the endoplasmic reticulum: Recent lessons from yeast and mammalian cell systems
Jeffrey L. Brodsky et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Limitations to the structure-based design of HIV-1 vaccine immunogens
Marc H. V. Van Regenmortel
JOURNAL OF MOLECULAR RECOGNITION (2011)
Neutralizing Monoclonal Antibodies against Hepatitis C Virus E2 Protein Bind Discontinuous Epitopes and Inhibit Infection at a Postattachment Step
Michelle C. Sabo et al.
JOURNAL OF VIROLOGY (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Secretion-and-capture cell-surface display for selection of target-binding proteins
J. A. Rakestraw et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2011)
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Xueling Wu et al.
SCIENCE (2011)
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
Mihai L. Azoitei et al.
SCIENCE (2011)
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid et al.
SCIENCE (2011)
Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
Iliyana Mikell et al.
PLOS PATHOGENS (2011)
Toward an Antibody-Based HIV-1 Vaccine
James A. Hoxie
ANNUAL REVIEW OF MEDICINE (2010)
Engineering of glycosylation in yeast and other fungi: current state and perspectives
Karen De Pourcq et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2010)
Correlates of Protection Induced by Vaccination
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Rational antibody-based HIV-1 vaccine design: current approaches and future directions
Laura M. Walker et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
M. Juliana McElrath et al.
IMMUNITY (2010)
Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
James D. Brien et al.
JOURNAL OF VIROLOGY (2010)
Role of Complex Carbohydrates in Human Immunodeficiency Virus Type 1 Infection and Resistance to Antibody Neutralization
James M. Binley et al.
JOURNAL OF VIROLOGY (2010)
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
Hugo Mouquet et al.
NATURE (2010)
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
Davide Corti et al.
PLOS ONE (2010)
Elicitation of structure-specific antibodies by epitope scaffolds
Gilad Ofek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
Bruno E. Correia et al.
STRUCTURE (2010)
Few and Far Between: How HIV May Be Evading Antibody Avidity
Joshua S. Klein et al.
PLOS PATHOGENS (2010)
Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein
Andreas Moerner et al.
JOURNAL OF VIROLOGY (2009)
Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology
Pieter P. Jacobs et al.
NATURE PROTOCOLS (2009)
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
Lei Chen et al.
SCIENCE (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
Antibody Binding Site Mapping of SARS-CoV Spike Protein Receptor-Binding Domain by a Combination of Yeast Surface Display and Phage Peptide Library Screening
Xiaoping Zhang et al.
VIRAL IMMUNOLOGY (2009)
Challenges for structure-based HIV vaccine design
William R. Schief et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling
Benjamin J. Hackel et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Highly L and D enantioselective variants of horseradish peroxidase discovered by an ultrahigh-throughput selection method
Eugene Antipov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies
Gary Frey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and BHIV-1 R5 isolates
Indresh K. Srivastava et al.
VIROLOGY (2008)
Structure of a high-affinity Mimotope peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies
Erica Ollmann Saphire et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein
Theodore Oliphant et al.
JOURNAL OF VIROLOGY (2006)
Humanization of yeast to produce complex terminally sialylated glycoproteins
Stephen R. Hamilton et al.
SCIENCE (2006)
A flow cytometric assay for screening improved heterologous protein secretion in yeast
J. Andy Rakestraw et al.
BIOTECHNOLOGY PROGRESS (2006)
Gene Designer: a synthetic biology tool for constructing artificial DNA segments
Alan Villalobos et al.
BMC BIOINFORMATICS (2006)
Directed evolution of the epidermal growth factor receptor extracellular domain for expression in yeast
YS Kim et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Isolating and engineering human antibodies using yeast surface display
Ginger Chao et al.
NATURE PROTOCOLS (2006)
Yeast surface display of a noncovalent MHC class II heterodimer complexed with antigenic peptide
ET Boder et al.
BIOTECHNOLOGY AND BIOENGINEERING (2005)
An episomal expression vector for screening mutant gene libraries in Pichia pastoris
CC Lee et al.
PLASMID (2005)
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies
BF Haynes et al.
SCIENCE (2005)
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
JA Binley et al.
JOURNAL OF VIROLOGY (2004)
Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12
R Pantophlet et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gpl120 is sterically restricted on primary human immunodeficiency virus type 1
AF Labrijn et al.
JOURNAL OF VIROLOGY (2003)
Production of complex human glycoproteins in yeast
SR Hamilton et al.
SCIENCE (2003)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
DD Richman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120
R Pantophlet et al.
JOURNAL OF VIROLOGY (2003)
Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
RW Sanders et al.
JOURNAL OF VIROLOGY (2002)
Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein
N Schülke et al.
JOURNAL OF VIROLOGY (2002)
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1
G Stiegler et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity
ET Boder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure
JM Binley et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
